These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 7019742)
1. A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells. Bubeník J; Cochran AJ; Todd G; Malkovský M; Jandlová T; Suhajová E; Boubelík M Neoplasma; 1981; 28(2):185-93. PubMed ID: 7019742 [TBL] [Abstract][Full Text] [Related]
2. Technical aspects of the macrophage electrophoretic mobility test in transplantation immunity. Malkovský M; Bubeník J; Holán V; Hasek M Folia Biol (Praha); 1979; 25(3):179-87. PubMed ID: 385372 [TBL] [Abstract][Full Text] [Related]
3. Experimental studies of tumor immunotherapy. I. Macrophage migration inhibitory activity as an immunological parameter. Hayashi S Acta Med Okayama; 1976 Apr; 30(2):95-106. PubMed ID: 135489 [TBL] [Abstract][Full Text] [Related]
4. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma. Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439 [TBL] [Abstract][Full Text] [Related]
5. [Kinetics of production of macrophage migration inhibitory factors in mixed culture of lymphocytes and tumor cells]. Kharkevich DD; Suslov AP Biull Eksp Biol Med; 1982 Feb; 93(2):53-5. PubMed ID: 6461371 [No Abstract] [Full Text] [Related]
6. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases. Jenssen R; Jenssen HL; Köhler H; Friemel H Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037 [TBL] [Abstract][Full Text] [Related]
7. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration]. Metzner G; Jäger L Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821 [TBL] [Abstract][Full Text] [Related]
8. Immune reactivity of spleen cells in advanced stages of tumor growth. Oisgold-Dagá S; Jasnis MA; Klein S; de Bonaparte YP Biomed Pharmacother; 1982; 36(6-7):319-23. PubMed ID: 6763881 [TBL] [Abstract][Full Text] [Related]
9. [In vitro reaction of lymph node cells of mice to protein and cell-bound antigens. A study with the macrophage electrophoretic mobility test ]. Schäffner H Allerg Immunol (Leipz); 1981; 27(3):145-52. PubMed ID: 6181671 [TBL] [Abstract][Full Text] [Related]
10. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors. Preece AW; Light PA Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199 [TBL] [Abstract][Full Text] [Related]
11. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells. McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840 [TBL] [Abstract][Full Text] [Related]
12. [Study of immunosuppressive effect of measles virus. In vitro effect of the leukocyte migration inhibition test (author's transl)]. Sakiyama Y Hokkaido Igaku Zasshi; 1980 Jul; 55(4):315-22. PubMed ID: 7009364 [TBL] [Abstract][Full Text] [Related]
13. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates. Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122 [TBL] [Abstract][Full Text] [Related]
14. Sensitization of normal mouse lymphocytes immunized in vitro as detected by macrophage electrophoretic mobility (MEM) test. Nĕmecková S; Bubeník J; Indrová M Folia Biol (Praha); 1982; 28(4):280-2. PubMed ID: 7141039 [TBL] [Abstract][Full Text] [Related]
15. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay. Borkowsky W; Suleski P; Bhardwaj N; Lawrence HS J Immunol; 1981 Jan; 126(1):80-2. PubMed ID: 6161170 [TBL] [Abstract][Full Text] [Related]
16. [The role of tumor hybrid cells in antitumor immunity. II. Comparison of antigenicity of tumor hybrid cells and ascitic hepatoma cells by leukocyte migration inhibition test]. Tong YX Zhonghua Zhong Liu Za Zhi; 1983 Jul; 5(4):259-61. PubMed ID: 6653340 [No Abstract] [Full Text] [Related]
17. Reactivity in neoplasia, preneoplasia, and pregnancy of lymphocytes against fetal extracts: cross-reactions between man and mouse. Pasternak G; Schlott B; Reinhöfer J; Gryschek G; von Broen B; Albrecht S J Natl Cancer Inst; 1982 Nov; 69(5):997-1004. PubMed ID: 6957663 [TBL] [Abstract][Full Text] [Related]
18. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF). Rocklin RE J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603 [No Abstract] [Full Text] [Related]
19. Applications of the macrophage electrophoretic mobility test (M.E.M.). Shenton BR Boll Ist Sieroter Milan; 1978 Jan; 56(6):557-64. PubMed ID: 629849 [TBL] [Abstract][Full Text] [Related]
20. Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivity. Geczy CL; Meyer PA J Immunol; 1982 Jan; 128(1):331-6. PubMed ID: 6172485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]